Allergy & Immunology Clinical Trials This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy
Condition: Food AllergyInterventions: Drug: Egg Oral Immunotherapy; Drug: Baked EggSponsors: Mount Sinai School of Medicine; Hugh.Sampson; National Institute of Allergy and Infectious Diseases (NIAID); Consortium of Food Allergy ResearchNot yet recruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2013 Category: Research Source Type: clinical trials

The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use
Conditions: Rabies Vaccine Allergy; Vaccination Adverse Event; Anti-D AntibodiesInterventions: Biological: Zagreb2-1-1; Biological: EssenSponsors: Beijing Center for Disease Control and Prevention; Beijing Center for Disease Control and PreventionRecruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2013 Category: Research Source Type: clinical trials

Intranasal AD4-H5-VTN as an Adenovirus Vaccine
Condition: Healthy VolunteerIntervention: Biological: Ad4-H5-VtnSponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2013 Category: Research Source Type: clinical trials

Circassia?s Toleromune Cat Allergy Treatment Maintains Symptom Improvement Two Years After Start of Short-Course Therapy
OXFORD, UK and SAN ANTONIO, USA – 25 February 2013 – Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study showing that a short course of just four doses of... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 25, 2013 Category: Pharmaceuticals Source Type: clinical trials

GREER Investigational Sublingual Allergy Immunotherapy Liquid (SAIL) for Short Ragweed Allergies Data From Phase III Trial Featured at Allergy Meeting
First Positive Findings from a Phase III Trial Evaluating Sublingual-Liquid Ragweed Pollen Extract in North America Presented at a Featured Poster Session at Prominent Allergy Meeting SAN ANTONIO--(BUSINESS WIRE)--Feb 25, 2013 - GREER®,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 25, 2013 Category: Pharmaceuticals Source Type: clinical trials

Circassia's ToleroMune Cat Allergy Treatment Maintains Symptom Improvement Two Years After Start of Short-Course Therapy
OXFORD, England and SAN ANTONIO, February 25, 2013 /PRNewswire/ --Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study showing that a short course of just four doses of... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 25, 2013 Category: Pharmaceuticals Source Type: clinical trials

Dyax Presents DX-2930 Data at the 2013 American Academy of Allergy, Asthma and Immunology Annual Meeting
DX-2930 is a Potent, Highly Specific, and Potentially Long-Acting Antibody Inhibitor of Plasma Kallikrein BURLINGTON, Mass.--(BUSINESS WIRE)--Feb 25, 2013 - Dyax Corp. (NASDAQ:DYAX) today announced results from a preclinical study of DX-2930, their... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 25, 2013 Category: Pharmaceuticals Source Type: clinical trials

Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic Asthma Patients in Relation to Allergic Status
Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic Asthma Patients in Relation to Allergic Status Data presented at the 2013 American Academy of Allergy, Asthma & Immunology Annual Meeting San Antonio, Texas, Feb. 23, 2013... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 25, 2013 Category: Pharmaceuticals Source Type: clinical trials

Additional QNASL (beclomethasone dipropionate) Nasal Aerosol Data to be Presented at Annual Allergy Meeting
Data to be Presented Regarding Impact on Sleep Quality and Nasal Symptom Relief at 24 Hours Post Dose in Patients with Seasonal and Perennial Allergic Rhinitis JERUSALEM--(BUSINESS WIRE)--Feb 22, 2013 - Teva Pharmaceutical Industries Ltd. announced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 22, 2013 Category: Pharmaceuticals Source Type: clinical trials

Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
Condition: DengueInterventions: Biological: TV003 Vaccine; Biological: Placebo VaccineSponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2013 Category: Research Source Type: clinical trials

Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
Condition: DengueInterventions: Biological: TV003 Vaccine; Biological: Placebo VaccineSponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2013 Category: Research Source Type: clinical trials

Details of HER-2/neu Class I Antigen Licensed by TapImmune published in Journal of Immunology: Antigen is a naturally processed epitope for breast cancer vaccines.
SEATTLE, Jan. 22, 2013 /PRNewswire/ -- TapImmune Inc. (OTCBB: TPIV) is pleased to announce the January publication of a paper titled "Enzymatic Discovery of a HER-2/neu Epitope That Generates Cross-Reactive T-cells", authored by Henle et al,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 25, 2013 Category: Pharmaceuticals Source Type: clinical trials

Children with egg allergies can safely receive flu vaccine, U-M study says
Egg allergic children did not have adverse reactions to single dose of influenza vaccine in multi-center study ANN ARBOR, Mich., Jan. 22, 2013 /PRNewswire-USNewswire/ -- Egg allergic children, including those with a history of anaphylaxis to egg,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 25, 2013 Category: Pharmaceuticals Source Type: clinical trials

Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Condition: NeoplasmsIntervention: Genetic: Blood and tumor samplesSponsors: Centre Leon Berard; Centre Leon BerardNot yet recruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2013 Category: Research Source Type: clinical trials

CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance; Type 1 DiabetesInterventions: Drug: CTLA4-Ig (Abatacept); Drug: PlaceboSponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); American Diabetes Association; Juvenile Diabetes Research FoundationNot yet recruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2013 Category: Research Source Type: clinical trials